Press release
Global Viscosupplementation Devices Market to Grow at a CAGR of 7.94% Through 2032 - Market Insights, Competitive Landscape, and Forecast | DelveInsight
Viscosupplementation Devices Market
Technological advancements in HA formulations, extended duration of therapeutic effects, and favorable reimbursement scenarios in several regions are contributing to market expansion. Moreover, increasing awareness among patients and healthcare providers about the benefits of viscosupplementation, such as improved joint mobility, pain relief, and delayed need for joint replacement, continues to support demand.
DelveInsight's Global Viscosupplementation Devices Market Insights report provides an in-depth analysis of the current market landscape, including key trends, growth drivers, restraints, and evolving opportunities. The report also features detailed company profiles, product portfolios, and strategic developments by leading players, offering comprehensive insights into the competitive landscape. With expert forecasting through 2032, this report is an essential resource for stakeholders looking to capitalize on the growing viscosupplementation segment within the orthopedic care market.
Explore the latest trends and growth drivers in the viscosupplementation devices market-download your sample report now https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Key Takeaways from the Viscosupplementation Devices Market Report
• The viscosupplementation devices market was valued at USD 4.08 billion in 2023 and is projected to grow at a CAGR of 7.94% from 2025 to 2032, reaching USD 6.43 billion by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global viscosupplementation devices market during the forecast period.
• Notable viscosupplementation device companies such as Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Sanofi, Smith & Nephew, Ferring B.V., Lifecore Biomedical, LLC, LG Chem, Fidia Farmaceutici S.p.A, OrthogenRx, Bioventus, DePuy Synthes (Johnson & Johnson), Vivacy, APTISSEN, KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED® GmbH, Juniper Biologics, Ono Pharmaceutical Co., Ltd., CarthroniX, Zimmer Biomet, and several others are currently operating in the viscosupplementation devices market.
• In July 2024, Anika announced the full market release of the IntegrityTM Implant System, a regenerative hyaluronic acid-based scaffold used for repairing rotator cuff and other tendon injuries.
• In January 2023, CarthroniX received a $5.0 million grant from the US Department of Defense to fund the planning phase and Phase I/IIA of a clinical study on CX-011. This study aimed to assess CX-011 for pain relief, increased function, and potential disease-modifying treatment for knee osteoarthritis.
To read more about the latest highlights related to the viscosupplementation devices market, get a snapshot of the key highlights entailed in the global viscosupplementation devices market report here https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Viscosupplementation Devices Overview
Viscosupplementation devices are used to administer hyaluronic acid directly into synovial joints, most commonly the knee, to relieve pain and improve mobility in patients with osteoarthritis. These devices offer a minimally invasive, non-surgical treatment option, particularly beneficial for individuals who do not respond well to first-line therapies like pain medications or physical therapy. By restoring joint lubrication and cushioning, viscosupplementation helps delay the need for joint replacement surgeries. With the growing prevalence of osteoarthritis and advancements in injection technologies, these devices are becoming an increasingly important tool in managing joint degeneration and enhancing patient quality of life.
Viscosupplementation Devices Market Insights
North America is anticipated to dominate the global viscosupplementation devices market through the forecast period, driven by the rising prevalence of osteoarthritis, a growing elderly population, and increasing demand for minimally invasive treatments. According to the CDC (2022), around 18.9% of U.S. adults have diagnosed arthritis, with rates rising significantly with age, up to 53.9% in those aged 75 and older. This growing patient pool, combined with a preference for non-surgical solutions like viscosupplementation, continues to drive demand. Additionally, strong government initiatives, public awareness campaigns such as Pain Awareness Month, and new product approvals-including Anika Therapeutics' expanded FDA clearance for Tactoset in 2023-further support market growth across the region.
To know more about why North America is leading the market growth in the viscosupplementation devices market, get a snapshot of the viscosupplementation devices market outlook here https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Viscosupplementation Devices Market Dynamics
According to the Global Burden of Disease (2023), nearly one billion people are projected to have osteoarthritis by 2050, with knee and hip joints most commonly affected. This rising prevalence-knee OA expected to grow by 74.9%, hip by 78.6%, and others by over 90%-is driving demand for effective, non-surgical pain management options like viscosupplementation devices. These devices, which involve injecting hyaluronic acid to lubricate and cushion joints, are gaining traction for their ability to relieve pain and improve joint function.
Global market growth is further fueled by strategic initiatives from key players. For example, in December 2023, Bioventus Inc. secured a nationwide contract with AetnaTM Medicare Advantage, enabling over 3 million members to access its HA-based treatment, DUROLANE. Modern advancements in hyaluronic acid technology-such as cross-linked formulations offering extended relief-are also enhancing treatment efficacy. Products like Cingal, which combines HA with corticosteroids, are setting new standards in OA pain relief.
Despite the promise, competition from alternative therapies like PRP, physical therapy, and oral medications, along with concerns around injection-related discomfort and infection, may limit adoption to some extent. Nonetheless, the growing OA burden continues to present a strong opportunity for innovation and expansion in the viscosupplementation devices market.
Get a sneak peek at the Viscosupplementation Devices market dynamics @ https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Coverage: Global
Study Period: 2022 to 2032
Viscosupplementation Devices Market CAGR: ~7.94%
Key Viscosupplementation Devices Companies: Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Sanofi, Smith & Nephew, Ferring B.V., Lifecore Biomedical, LLC, LG Chem, Fidia Farmaceutici S.p.A, OrthogenRx, Bioventus, DePuy Synthes (Johnson & Johnson), Vivacy, APTISSEN, KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED® GmbH, Juniper Biologics, Ono Pharmaceutical Co., Ltd., CarthroniX, Zimmer Biomet, and others.
Viscosupplementation Devices Market Segmentation
Market Segmentation By Product Type: Single Injection, Three Injections, and Five Injections.
Market Segmentation By End User: Hospitals, Orthopedic Clinics, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the viscosupplementation devices market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. Viscosupplementation Devices Market Report Introduction
2. Viscosupplementation Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Viscosupplementation Devices Market Key Factors Analysis
6. Viscosupplementation Devices Market Porter's Five Forces Analysis
7. Viscosupplementation Devices Market Layout
8. Viscosupplementation Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Viscosupplementation Devices Market to Grow at a CAGR of 7.94% Through 2032 - Market Insights, Competitive Landscape, and Forecast | DelveInsight here
News-ID: 4054156 • Views: …
More Releases from DelveInsight
Insulin Resistance Pipeline Insight 2025: Pipeline Drugs, Metabolic Pathway Modu …
DelveInsight's "Insulin Resistance - Pipeline Insight, 2025" explores over 10+ therapies in development for insulin resistance, a metabolic condition strongly linked to type 2 diabetes, obesity, and cardiovascular disease. Despite lifestyle modification and insulin-sensitizing drugs like metformin being mainstays of management, many patients continue to face poor glycemic control and associated complications, underscoring the need for more effective insulin resistance treatments.
The insulin resistance pipeline is broadening with next-generation therapies targeting…
Uveal Melanoma Pipeline Insight 2025: 30+ Pipeline Drugs, Targeted Therapies, an …
DelveInsight's "Uveal Melanoma - Pipeline Insight, 2025" explores over 30+ therapies in development for uveal melanoma, a rare and aggressive intraocular malignancy with high metastatic potential, most commonly to the liver. Despite surgery and radiotherapy being standards for localized disease, patients with metastatic uveal melanoma face limited systemic treatment options, creating significant unmet needs in the uveal melanoma treatment landscape.
The uveal melanoma pipeline is diversifying with next-generation targeted therapies, including…
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,…
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trial …
DelveInsight's "Vaso-Occlusive Crisis (VOC) Associated With Sickle Cell Disease - Pipeline Insight, 2025" provides an in-depth analysis of emerging therapies targeting vaso-occlusive crisis (VOC), a severe and recurring complication of sickle cell disease. Despite current standards of care, including hydroxyurea, patients continue to experience frequent vaso occlusive sickle cell crisis, underscoring the urgent need for effective interventions in sickle cell anemia vaso occlusive crisis treatment.
The VOC pipeline is diversifying with…
More Releases for Viscosupplementation
Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical…
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost…
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in…
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation…
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
